| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | HORIZON PHARMA PLC | 220,000 | 4,360,000 | 0.71% | ||
| 52 | ANTHEM INC | 30,000 | 4,200,000 | 0.69% | ||
| 53 | AGIOS PHARMACEUTICALS INC | 54,000 | 3,812,000 | 0.62% | ||
| 54 | BRISTOL MYERS SQUIBB CO | 60,000 | 3,552,000 | 0.58% | ||
| 55 | ALKERMES PLC | 59,000 | 3,462,000 | 0.56% | ||
| 56 | HALOZYME THERAPEUTICS INC | 246,000 | 3,304,000 | 0.54% | ||
| 57 | CERNER CORP | 55,000 | 3,298,000 | 0.54% | ||
| 58 | AKORN INCORPORATED | 112,470 | 3,206,000 | 0.52% | ||
| 59 | ZAFGEN INC COM | 100,000 | 3,195,000 | 0.52% | ||
| 60 | HOLOGIC INC | 81,000 | 3,170,000 | 0.52% | ||
| 61 | HCA HOLDINGS INC | 40,000 | 3,094,000 | 0.50% | ||
| 62 | MERCK & CO INC | 60,000 | 2,963,000 | 0.48% | ||
| 63 | Dentsply Intl Inc | 58,400 | 2,953,000 | 0.48% | ||
| 64 | LILLY ELI & CO | 35,000 | 2,929,000 | 0.48% | ||
| 65 | ACHILLION PHARMACEUTICALS IN | 420,000 | 2,902,000 | 0.47% | ||
| 66 | MASIMO CORP | 75,000 | 2,892,000 | 0.47% | ||
| 67 | ARIAD PHARMACEUTICALS ORD (NMS) | 495,000 | 2,891,000 | 0.47% | ||
| 68 | STERICYCLE INC | 20,000 | 2,786,000 | 0.45% | ||
| 69 | COOPER COS INC | 18,500 | 2,754,000 | 0.45% | ||
| 70 | VARIAN MED SYS INC | 37,000 | 2,730,000 | 0.45% | ||
| 71 | PFIZER INC | 85,000 | 2,670,000 | 0.44% | ||
| 72 | NEKTAR THERAPEUTICS COM | 240,000 | 2,650,000 | 0.43% | ||
| 73 | NOVADAQ TECHNOLOGIES INC | 250,000 | 2,608,000 | 0.43% | ||
| 74 | NEUROCRINE BIOSCIE COM USD0.001 | 65,000 | 2,586,000 | 0.42% | ||
| 75 | ALNYLAM PHARMACEUTICALS INC | 32,000 | 2,572,000 | 0.42% | ||
| 76 | THERMO FISHER SCIENTIFIC INC | 20,000 | 2,446,000 | 0.40% | ||
| 77 | Heartware International, Inc. | 45,000 | 2,354,000 | 0.38% | ||
| 78 | TELEFLEX INC | 18,557 | 2,305,000 | 0.38% | ||
| 79 | NOVAVAX INC COM | 325,000 | 2,298,000 | 0.37% | ||
| 80 | MEDIVATION INC | 52,600 | 2,236,000 | 0.36% | ||
| 81 | HEALTHCARE SVCS GRP INC | 65,000 | 2,191,000 | 0.36% | ||
| 82 | NUVASIVE INC | 45,000 | 2,170,000 | 0.35% | ||
| 83 | QIAGEN NV | 80,000 | 2,064,000 | 0.34% | ||
| 84 | Ultra NASDAQ Biotechnology | 35,000 | 2,039,000 | 0.33% | ||
| 85 | ACADIA PHARMACEUTICALS INC COM | 59,000 | 1,951,000 | 0.32% | ||
| 86 | SEATTLE GENETICS INC | 48,000 | 1,851,000 | 0.30% | ||
| 87 | GLOBUS MED INC | 87,700 | 1,812,000 | 0.30% | ||
| 88 | MACROGENICS INC | 83,000 | 1,778,000 | 0.29% | ||
| 89 | BLUEBIRD BIO INC COM | 20,500 | 1,754,000 | 0.29% | ||
| 90 | WELLCARE HEALTH PLANS INC | 20,000 | 1,724,000 | 0.28% | ||
| 91 | CELLDEX THERAPEUTICS INC NEW | 160,000 | 1,686,000 | 0.27% | ||
| 92 | BAXTER INTL INC | 50,000 | 1,643,000 | 0.27% | ||
| 93 | INOVIO PHARMACEUTICALS INC | 265,000 | 1,532,000 | 0.25% | ||
| 94 | ABBVIE INC | 27,000 | 1,469,000 | 0.24% | ||
| 95 | DAVITA INC | 20,000 | 1,447,000 | 0.24% | ||
| 96 | INTERCEPT PHARMACEUTICALS INCORPORATED | 8,700 | 1,443,000 | 0.24% | ||
| 97 | ALDER BIOPHARMACEUTICALS INC | 43,000 | 1,409,000 | 0.23% | ||
| 98 | JUNO THERAPEUTICS INC COM | 33,000 | 1,343,000 | 0.22% | ||
| 99 | ANGIODYNAMICS INC | 100,000 | 1,319,000 | 0.22% | ||
| 100 | MYRIAD GENETICS INC | 33,000 | 1,237,000 | 0.20% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011338, filed 2015.11.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
